QOF database

Home | News | Downloads
DR. HUNTER & PARTNER

DR. HUNTER & PARTNER

DONAGHCLONEY SURGERY, DONAGHCLONEY SURGERY, 60A MAIN STREET, DONAGHCLONEY, CRAIGAVON

HF 4

The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.

IndicatorYearNumeratorDenominatorRatioCentile
HF 4 2010 7 11 63.6%
HF 4 2011 9 11 81.8%
HF 4 2012 8 11 72.7%
HF 4 2013 12 15 80.0%
HF004 2014 18 22 81.8%
HF004 2015 18 22 81.8%
HF004 2016 17 21 81.0%
HF004 2017 16 21 76.2%
HF004 2018 14 18 77.8%
HF004 2019 26 33 78.8%
HF004 2020 24 28 85.7%
HF004 2021 21 26 80.8%